PATENT CLAIM ANALYSIS

Application Number: 16157007
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "294000"]

Abstract:
Provided herein are pharmaceutical compositions comprising a vesicular monoamine transporter 2 (VMAT2) inhibitor (e.g., deutetrabenazine) and an excipient useful for treating stuttering in a subject in need thereof. Further provided are methods of treating stuttering in a subject in need thereof comprising administering an effective amount of a pharmaceutical composition of the present disclosure. Also provided herein are kits comprising such pharmaceutical compositions.

Claim (Index 17):
A kit comprising:\n a) a pharmaceutical composition comprising an excipient and an effective amount of a VMAT2 inhibitor to treat stuttering ; and b) a package insert comprising instructions for administering the pharmaceutical composition to a human subject suffering from one of more signs or symptoms of stuttering.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 97.0
- Lexical Diversity: 1.61364
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15030271', '15116786', '15278192', '14735396', '13489516']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7260841223861242
- 35 USC 102 Novelty (BERT): 0.4928833746112213
- Combined Prediction Score: 0.702764047608634
- Mean Citation Score: 174.34380800000002
- Max Citation Score: 213.72836
- Similarity Product: 150.49424314037805

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test